Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Net Equity Issued and Repurchased (2017)

Solid Biosciences' Net Equity Issued and Repurchased history spans 1 years, with the latest figure at -$500000.0 for Q2 2017.

  • For Q2 2017, Net Equity Issued and Repurchased changed N/A year-over-year to -$500000.0; the TTM value through Dec 2017 reached $24.5 million, changed N/A, while the annual FY2017 figure was $24.5 million, N/A changed from the prior year.
  • Net Equity Issued and Repurchased for Q2 2017 was -$500000.0 at Solid Biosciences, down from $25.0 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $25.0 million in Q1 2017 and bottomed at -$500000.0 in Q2 2017.